Related Experiment Video
Updated: Jan 17, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Prevention of Lead Exposure in the Perinatal Period
Insights
Prenatal lead screening is crucial for preventing fetal exposure, as no blood lead level is safe. Universal screening during pregnancy can identify risks and protect maternal and infant health, especially for minority populations.
Area of Science:
- Environmental Health
- Pediatric Health
- Maternal Health
Background:
- Established knowledge on childhood lead exposure effects and pediatric screening.
- Limited focus on lead exposure prevention during the perinatal period.
- Inconsistent prenatal lead screening guidelines and practices.
Purpose of the Study:
- To review existing guidelines and practices for prenatal lead screening.
- To make recommendations for primary, secondary, and tertiary prevention of lead exposure.
- To advocate for universal lead screening during pregnancy.
Main Methods:
- Review of current literature on lead exposure and screening guidelines.
- Analysis of variability in screening practices.
- Examination of risks associated with in utero lead exposure.
Main Results:
- No safe blood lead level exists; maternal bone lead can expose the fetus.
- Disproportionately high blood lead levels in women and children of color.
- In utero lead exposure linked to preterm birth, low birth weight, and neurodevelopmental delays.
Conclusions:
- Prenatal lead screening via blood tests and history is vital for exposure mitigation.
- Universal lead screening during pregnancy is recommended.
- Addressing lead exposure disparities in minority populations is essential.
Abstract:
The effects of lead exposure on children and the importance of lead screening in the pediatric period are well-established, but little emphasis is placed on prevention in the perinatal period. Variability in screening guidelines and practices results in inconsistent and often insufficient lead screening during pregnancy. No blood lead level is safe, and lead stored in a woman's bones can be released during pregnancy, exposing the fetus. Women and children of color face disproportionately high blood lead levels as compared with their White counterparts. In utero exposure to lead is associated with preterm birth, low birth weight, and neurodevelopmental delays in children. Prenatal lead screening through blood tests and occupational and social history can help to identify, prevent, and mitigate maternal and fetal exposure. In this article, I review existing guidelines and practices; make recommendations for primary, secondary, and tertiary prevention of lead; and advocate for universal lead screening during pregnancy.
Related Concept Videos
01:07Teratogenicity
01:19Rh Blood Group
01:30Preventive Healthcare Services
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...